CYP1B1 and breast carcinoma: later demonstrated that CYP1B1 did not directly inactivate docetaxel because the cytotoxicity of docetaxel in MCF‐7 breast cancer cells was not affected by silencing CYP1B1 or adding recombinant CYP1B1.53